PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 101 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $22,000 | -78.8% | 5,700 | -81.2% | 0.00% | -80.0% |
| Q3 2019 | $104,000 | -61.6% | 30,400 | -47.3% | 0.01% | -47.4% |
| Q2 2019 | $271,000 | -7.8% | 57,700 | -34.4% | 0.02% | -17.4% |
| Q1 2019 | $294,000 | -29.7% | 87,900 | -44.1% | 0.02% | -32.4% |
| Q4 2018 | $418,000 | -52.5% | 157,200 | 0.0% | 0.03% | +70.0% |
| Q3 2018 | $880,000 | -30.0% | 157,200 | -36.6% | 0.02% | -16.7% |
| Q2 2018 | $1,258,000 | -26.3% | 248,037 | -0.9% | 0.02% | -27.3% |
| Q1 2018 | $1,708,000 | +154.9% | 250,367 | +182.0% | 0.03% | +153.8% |
| Q4 2017 | $670,000 | +41.6% | 88,773 | +8.1% | 0.01% | +44.4% |
| Q3 2017 | $473,000 | – | 82,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,360,000 | $6,895,000 | 5.06% |
| Omega Fund Management, LLC | 778,230 | $3,946,000 | 2.91% |
| BVF INC/IL | 5,346,838 | $27,108,000 | 2.65% |
| Virtus ETF Advisers LLC | 152,550 | $773,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 842,632 | $4,272,000 | 0.59% |
| Tekla Capital Management LLC | 2,087,380 | $10,583,000 | 0.40% |
| Schonfeld Strategic Advisors LLC | 828,600 | $4,201,000 | 0.23% |
| Orbimed Advisors | 3,140,000 | $15,920,000 | 0.19% |
| Lombard Odier Asset Management (USA) Corp | 563,878 | $2,859,000 | 0.19% |
| Rhenman & Partners Asset Management AB | 300,000 | $1,521,000 | 0.16% |